News | July 11, 2007

GE, Abbott Labs Call Off $8.13 Billion Diagnostics Deal

A WALL STREET JOURNAL ONLINE NEWS ROUNDUP
July 11, 2007 - General Electric Co. and Abbott Laboratories announced they have terminated GE's $8.13 billion deal to buy Abbott's primary in-vitro and point-of-care diagnostics businesses.

In separate statements, the companies said they were unable to agree on "final terms and conditions" of the proposed deal. As a result, according to GE's statement, the companies "agreed it was in the best interests of both companies to mutually terminate their agreement and discussions."

The acquisition would have marked GE's entry into what is known as "in vitro" diagnostics, or laboratory testing, while Abbott would have shed a unit growing more slowly than other parts of its business. In vitro" diagnostics generally test blood or urine for diseases from cancer to HIV. Germany's Siemens AG, a GE rival in medical equipment, entered the market last year by paying $5.3 billion for Bayer AG's diagnostic unit.

The Abbott unit had sales of roughly $2.5 billion last year. GE would also have acquired Abbott's smaller point-of-care diagnostic group, which makes testing tools used at the bedside in hospitals, among other diagnostic tools.

Source: The Wall Street Journal Online

For more information: www.gehealthcare.com and www.abbott.com

Related Content

Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.
Technology | Quality Assurance (QA) | April 27, 2018
Sun Nuclear Corp. released significant new functionality for its SunCheck Platform for patient and machine quality...
Barco Highlights Imaging Workflow Compliance at HIMSS18
News | Flat Panel Displays | February 21, 2018
Barco will showcase its full line of radiology and mammography display systems with online quality assurance (QA)...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
Technology | PACS | January 22, 2018
QualiTest Group recently announced its improved Virtual Radiology Environment (VRE) testing solution for picture...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
News | Ultrasound Imaging | November 17, 2017
CIRS Inc. recently announced the acquisition of ATS Laboratories in Bridgeport, Conn. This merger brings together both...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
Volpara Solutions to Showcase VolparaEnterprise Live! at RSNA
News | Mammography | October 16, 2017
Volpara Solutions will introduce VolparaEnterprise Live!, a mammography quality control tool, at the 2016 Radiological...
CIRS Launches New MRI Distortion Check Software
Technology | Magnetic Resonance Imaging (MRI) | September 06, 2017
MRI Distortion Check is a new, cloud-based solution designed to quickly and automatically quantify distortion in...
RaySafe Introduces Pro-Slit Camera for Accurate Focal Spot Measurement
Technology | Digital Radiography (DR) | June 27, 2017
Unfors RaySafe recently introduced the RaySafe Pro-Slit Phantom and the RaySafe Pro-Stand.
Overlay Init